5-Chloro-1H-benzo[d][1,3]oxazine-2,4-dione

Catalog No.: 
ACSREL620
CAS No.: 
20829-96-3
Molecular Formula: 
C8H4ClNO3
Molecular Weight: 
197.58
5-Chloro-1H-benzo[d][1,3]oxazine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$80.00In stockIn stock
25g98%$324.00In stockIn stock
100g98%$875.00In stockInquiry
500g98%$4200.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-1H-benzo[d][1,3]oxazine-2,4-dione
IUPAC Name5-chloro-2H-benzo[d][1,3]oxazine-2,4(1H)-dione
MDL No.MFCD09032504
Molecular FormulaC8H4ClNO3
Molecular Weight197.58
SMILESO=C(NC1=CC=CC(Cl)=C12)OC2=O
InChI KeyNIGOFAVNIBBNJV-UHFFFAOYSA-N
Synonym5-chloro-2H-3,1-benzoxazine-2,4(1H)-dione | 5-chloro-2,4-dihydro-1H-3,1-benzoxazine-2,4-dione
CAS No.20829-96-3
PubChem CID639058

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSREL620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQPUY607 route compound structure diagram
    ACQPUY6072148-56-3In Stock
  2. Then
  3. ACSREL620 route product structure diagram
    ACSREL62020829-96-3In Stock
Inquiry

2. ACSREL620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQPUY607 route compound structure diagram
    ACQPUY6072148-56-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSREL620 route product structure diagram
    ACSREL62020829-96-3In Stock
Inquiry

3. ACSREL620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQPUY607 route compound structure diagram
    ACQPUY6072148-56-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSREL620 route product structure diagram
    ACSREL62020829-96-3In Stock
Inquiry

Comments (0)